Synteract and HCR Complete Merger to Become Global CRO

Related tags Clinical trial

Synteract and HCR merge
Synteract and HCR merge
Following its acquisition of HCR, Synteract has become a multinational CRO with a presence in 16 countries.

The completed deal sees CRO (contract research organization) Synteract takeover Munich-based Harrison Clinical Research to become SynteractHCR, creating a combined workforce of over 800 operating in 16 countries.

Speaking in January​ to Outsourcing-Pharma.com, a spokesman said that the acquisition was motivated by global expansion, allowing the company to have a “strong geographical presence in Western and Eastern Europe and an emerging presence in South America.”

Headquartered in San Diego, California, the company will offer its clients clinical support in drug development and managing Phase I-IV clinical trials across multiple therapeutic areas.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers